These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
831 related items for PubMed ID: 26907530
1. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid. Hammers CM, Stanley JR. Annu Rev Pathol; 2016 May 23; 11():175-97. PubMed ID: 26907530 [Abstract] [Full Text] [Related]
2. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid. Dainichi T, Chow Z, Kabashima K. J Dermatol Sci; 2017 Dec 23; 88(3):265-270. PubMed ID: 28747266 [Abstract] [Full Text] [Related]
3. Diagnosis and classification of pemphigus and bullous pemphigoid. Kershenovich R, Hodak E, Mimouni D. Autoimmun Rev; 2014 Dec 23; 13(4-5):477-81. PubMed ID: 24424192 [Abstract] [Full Text] [Related]
5. Immunodiagnosis of pemphigus and mucous membrane pemphigoid. Challacombe SJ, Setterfield J, Shirlaw P, Harman K, Scully C, Black MM. Acta Odontol Scand; 2001 Aug 21; 59(4):226-34. PubMed ID: 11570526 [Abstract] [Full Text] [Related]
6. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen. Korman NJ, Stanley JR, Woodley DT. Arch Dermatol; 1991 Mar 21; 127(3):387-90. PubMed ID: 1998370 [Abstract] [Full Text] [Related]
7. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari. Atzori L, Deidda S, Aste N. G Ital Dermatol Venereol; 2008 Feb 21; 143(1):1-8. PubMed ID: 18833046 [Abstract] [Full Text] [Related]
8. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Stanley JR. Adv Immunol; 1993 Feb 21; 53():291-325. PubMed ID: 8512037 [No Abstract] [Full Text] [Related]
9. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know]. Ingen-Housz-Oro S, Hüe S, Grootenboer-Mignot S, André C. Ann Dermatol Venereol; 2013 Feb 21; 140(8-9):563-70. PubMed ID: 24034645 [No Abstract] [Full Text] [Related]
10. Immunopathologic mechanisms in pemphigus and bullous pemphigoid. Jordon RE, Kawana S, Fritz KA. J Invest Dermatol; 1985 Jul 21; 85(1 Suppl):72s-78s. PubMed ID: 3891883 [Abstract] [Full Text] [Related]
11. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen. Takahashi H, Wada T, Matsuo S, Iwatsuki K, Iizuka H. J Dermatol; 1995 Aug 21; 22(8):576-81. PubMed ID: 7560455 [Abstract] [Full Text] [Related]
12. Recent advances in the understanding and treatment of pemphigus and pemphigoid. Yamagami J. F1000Res; 2018 Aug 21; 7():. PubMed ID: 30228865 [Abstract] [Full Text] [Related]
13. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus. Brooks WS, Lee YY, Abell E, Deng JS. J Clin Lab Anal; 1989 Aug 21; 3(5):307-11. PubMed ID: 2681622 [Abstract] [Full Text] [Related]
18. Human amnion membrane as a substrate for the detection of autoantibodies in pemphigus vulgaris and bullous pemphigoid. Sezin T, Avitan-Hersh E, Indelman M, Moscona R, Sabo E, Katz R, Pollack S, Bergman R. Isr Med Assoc J; 2014 Apr 21; 16(4):217-23. PubMed ID: 24834757 [Abstract] [Full Text] [Related]
19. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid. Cozzani E, Drosera M, Parodi A, Carrozzo M, Gandolfo S, Rebora A. Acta Derm Venereol; 2004 Apr 21; 84(5):381-4. PubMed ID: 15370705 [Abstract] [Full Text] [Related]
20. Combined features of pemphigus foliaceus and bullous pemphigoid: immunoblot and immunoelectron microscopic studies. Ishiko A, Hashimoto T, Shimizu H, Masunaga T, Nishibori Y, Watanabe K, Nishikawa T. Arch Dermatol; 1995 Jun 21; 131(6):732-4. PubMed ID: 7778933 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]